We are thinking of you and your families. Thank you!
The current COVID-19 pandemic is presenting unprecedented challenges to global healthcare systems, care teams, and communities. Intuitive is committed to doing all we can—prioritizing support of our customers and teams and undertaking measures to help slow the COVID-19 spread in our communities and ultimately defeat the pandemic. 
Ion by Intuitive
Ion by Intuitive has redefined navigational bronchoscopy. Powered by the novel and unique shape - sensing technology, Ion is the newest robotic platform from Intuitive (makers of da Vinci) for peripheral lung biopsy.

Upcoming Webinar
July 7th, 2020: CHEST Webinar

Learn about Implications of Shape-Sensing Robotic Bronchoscopy in a Lung Cancer Practice
Hear Dr. Folch, Dr. Reisenauer, and
Dr. Parikh’s perspective on robotic bronchoscopy as a value added practice to their Thoracic Oncology Program.

Tuesday, July 7th 2020, 3 pm - 4 pm CT
Clinical Resources
Late breaking abstract
Preliminary data is released on PRECIsE study focusing on nodules < 2 cm : “A prospective, Multi-Center Evaluation on the Clinical Utility of the Ion Endoluminal System - Experience Using a Robotic-Assisted Bronchoscopy System with Shape-Sensing Technology”
Exclusive interview with first human use study investigator

Dr. David Fielding shares his first human use experience with a robotic-assisted bronchoscopy system for lung nodule biopsy, developed by Intuitive.
Preclinical study: PRECISION - 1
On Demand: Webinars
Matthew J. Bott, Memorial Sloan Kettering Cancer Center
Bernard J. Park, Memorial Sloan Kettering Cancer Center
Supported by Intuitive
View video on the first Ion robotic bronchoscopy and da Vinci robotic resection for a solitary pulmonary nodule by the same team: Drs. Matthew Inra and Janani Reisenauer at Mayo Rochester.
Watch recorded webinar presented by Ion users Dr. Erik Folch and Dr. Sebastian Fernandez-Bussy on robotic-assisted bronchoscopy powered by shape-sensing technology.
What Makes Ion Unique:
Shape - Sensing Technology
Embedded in Ion's fully articulating catheter wall, Ion's fiber optic shape sensor provides precise location and shape information throughout the whole navigation and biopsy process. Combining these real-time measurements, with robotic control algorithms allows the Ion catheter to hold its position once the target nodule is reached. Once nodule is reached, the catheter locks in place to provide the stability needed for precise placement of biopsy tools.
Ion is for sale in the U.S.

Outside of the U.S., Ion is not CE Marked and not for human use. Ion cannot be placed on the market or put into service. Ion may not have regulatory approvals in all markets. Please check with your local Intuitive representative.

Important Safety Information

Risks associated with bronchoscopy through an endotracheal tube and under general anesthesia are infrequent and typically minor, and may include but are not limited to: sore throat, hoarseness, respiratory complications including dyspnea or hypoxemia, airway injury, bronchospasm, laryngospasm, fever, hemoptysis, chest or lung infection including pneumonia, lung abscess or an adverse reaction to anesthesia. Although rare, the following complications may also occur: bleeding, pneumothorax (collapsed lung), cardiac related complications, respiratory failure, air embolism, or death. As with other medical procedures, there may be additional risks associated with the use of general anesthesia and/or endotracheal intubation which are not listed above; you should consult a health care professional regarding these and other potential risks.

Procedures using the Ion Endoluminal System may be associated with longer procedure and/or longer anesthesia time.

Product names are trademarks or registered trademarks of Intuitive Surgical or their respective owners. See  www.intuitive.com/trademarks .